HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linda Castaldo Selected Research

Neoplasms (Cancer)

10/2012ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion.
1/2006OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linda Castaldo Research Topics

Disease

2Neoplasms (Cancer)
10/2012 - 01/2006
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2012
1Mast-Cell Leukemia (Leukemia, Mast Cell)
08/2005

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
10/2012 - 08/2005
2OSI 930IBA
01/2006 - 08/2005
1GTPase-Activating Proteins (GTPase-Activating Protein)IBA
10/2012
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2012
1Monomeric GTP-Binding ProteinsIBA
10/2012
1rho GTPase-activating proteinIBA
10/2012
1Tyrosine (L-Tyrosine)FDA Link
08/2005
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2005
1Phosphotransferases (Kinase)IBA
08/2005
1ThiophenesIBA
08/2005